Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 36,600 shares, a decline of 21.8% from the November 15th total of 46,800 shares. Currently, 5.8% of the shares of the company are short sold. Based on an average trading volume of 518,100 shares, the days-to-cover ratio is currently 0.1 days.

Autonomix Medical Stock Performance

Shares of AMIX stock traded up $0.04 during trading hours on Friday, reaching $3.19. The company had a trading volume of 50,521 shares, compared to its average volume of 222,710. The business has a fifty day moving average price of $9.37 and a 200-day moving average price of $15.98. Autonomix Medical has a one year low of $3.01 and a one year high of $152.00. The firm has a market cap of $3.67 million and a PE ratio of -0.20. The company has a debt-to-equity ratio of 0.36, a quick ratio of 4.26 and a current ratio of 4.26.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH started coverage on shares of Autonomix Medical in a research note on Tuesday, September 3rd. They issued a “buy” rating and a $28.00 price target for the company.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.